Share this article on:

Manufacturers News

doi: 10.1097/01.HJ.0000526537.70995.7d
Manufacturers News

Manufacturers News covers the latest products, programs, and news from hearing health care companies. News releases and photographs are welcome. Please submit information to HJ@wolterskluwer.com.

Back to Top | Article Outline

BELTONE EXTENDS BENEFITS TO SEVERE TO PROFOUND HEARING LOSS

The GN Hearing company Beltone (https://http://www.beltone.com/index.aspx) has launched Beltone Boost Max, building on the Beltone Trust's capabilities and extending their benefits to those with severe to profound hearing loss. The company said their data show that Beltone Boost Max users can hear sounds around them up to 60 percent more clearly and can understand up to 60 percent more speech in noise thanks to the hearing aid's CrossLink Directionality 2 feature. It monitors the user's surroundings and automatically switches to the most natural speech focus setting. Users will also benefit from Belton's fitting and remote care technologies, receiving a more client-centric fit and fine-tunings on request through Beltone's mobile app. They can also adjust and control their hearing aids through their iPhone, iPad, iPod touch, and most Android devices.

Back to Top | Article Outline

CLEMENTINE WEAR WINS NSF COMPETITION

The cloud/mobile-based audio platform Clementine Wear developed by Samplified Audio (http://http://www.askclementine.com/) has won the Hearables Challenge, which was hosted by the National Science Foundation (NSF) to find solutions that could improve the clarity of conversation in noisy settings. Clementine Wear personalizes sound based on the listener's audio profile. It was selected by a panel of experts from the NSF, NineSigma, and NASA, with the support of the Linguistic Data Consortium of the University of Pennsylvania, after they reviewed all submissions’ speech-in-noise handling, latency, and application potential to consumer-grade devices. Samplified Audio has developed the SnowOwl, the first product utilizing Clementine Wear that can serve as a music player or listening device. It is now available on the crowdfunding platform Indiegogo.

Back to Top | Article Outline

SENS-401 GETS FDA ORPHAN DRUG DESIGNATION

SENS-401, a therapy in development for the treatment of chemotherapy-induced hearing loss by Sensorion (http://http://www.sensorion-pharma.com/en/), has been given the orphan drug designation by the U.S. Food and Drug Administration (FDA), which provides incentives like tax credit and FDA assistance for companies to create products for rare diseases. SENS-401 is a drug candidate that aims to protect and preserve inner ear tissue when lesions can cause progressive or sequelar hearing impairments and prevent platinum-induced ototoxicity in pediatric patients. Platinum-induced chemotherapies, particularly cisplatin, are commonly used to treat cancer, but induce severe hearing loss in 50 to 60 percent of treated patient. There is currently no approved pharmaceutical treatment available for this pathology.

Back to Top | Article Outline

STARKEY INTRODUCES IMMERSIVE HEARING AIDS

Starkey Hearing Technologies (http://http://www.starkey.com/) has launched the new iQ hearing aid line designed to create an immersive hearing experience for users, based on the company's research in virtual reality, advanced neuroscience, and audiology and signal processing. The iQ product lines include Muse iQ wireless hearing aids; SoundLens Synergy iQ, a new invisible-in-the-canal hearing aid; Halo iQ, smartphone-compatible hearing aids; and the new wireless accessory TruLink Remote. The iQ technologies feature acuity immersion, which leverages microphone placement to aid with high-frequency information for improved sound quality and spatial awareness. They also have acuity immersion directionality, which restores front-to-back cues; speech indicators for memory, which provide descriptive names for memory environments; and smart VC, which allows for an increase in gain in all channels. All iQ products are now available.

Back to Top | Article Outline

OTICON CELEBRATES A DECADE OF SUPPORT FOR BREAST CANCER AWARENESS

Oticon (https://http://www.oticon.com/) celebrates 10 years of its annual campaign “Hear in Pink,” which delivers messages to promote hearing health and breast cancer awareness and has raised over $100,000 to support non-profit breast cancer organizations. For this year's “Hear in Pink,” Oticon will donate a portion of all sales of the special edition pink Oticon Opn and all Oticon Opn hearing aids in September and October to the National Breast Cancer Coalition. Like previous years, Oticon will partner with hearing health professionals to engage and educate local communities through the campaign's media and social media outreach. Hearing health professionals are encouraged to like Oticon's Facebook page, show their support by wearing specially designed “Hear in Pink” T-shirts, and participate in their local Breast Cancer walks.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.